Skip to main content
. 2015 Mar 1;8(3):2300–2310.

Figure 2.

Figure 2

Effect of Sorcin silencing on cell proliferation in human myeloma cell lines. Cells were untransfected (Control), or transfected with Sorcin shRNA#1 or shRNA#2, and then incubated with different concentrations of cisplatin, as indicated for an additional 48 h. Cell survival was determined using the MTS assay. Data are mean ± SD of three independent experiments; *P<0.05 compared with untransfected control cells.